Cambridge Innovation Capital
Status
Active
Global HQ
Cambridge, United Kingdom
Countries of investment
- United Kingdom (esp. Cambridge spinouts)
Investment stages
- Seed
- Series A
- Series B
Industries
- Deeptech
About
Cambridge Innovation Capital is a research‑led VC affiliated with Cambridge University. Fund III targets UK spinouts in TechBio and deep tech, supporting founders via investor capital and EIR programming.
Cambridge Innovation Capital is a research‑led VC affiliated with Cambridge University. Fund III targets UK spinouts in TechBio and deep tech, supporting founders via investor capital and EIR programming.
Investment Thesis
Invests in University of Cambridge spinouts in deep tech and life sciences from seed through early scaling.
Manager's Experience
With a robust background in venture capital, the fund manager has actively engaged in over 50 investments across technology and healthcare sectors, primarily within North America and Europe. Leveraging a data-driven approach, they focus on early to growth-stage companies, emphasizing operator-first strategies that enhance operational efficiency. Notable exits include successful mergers and public offerings, reflecting a strong track record of generating value for stakeholders. Their thematic investment philosophy prioritizes innovation and transformative potential, positioning the portfolio for sustained growth.
Team
Robert Sprawson – Partner
Chief Financial Officer and Board Member
Andrew Williamson Ph.D – Managing Partner & Board Member
Anne Horgan Ph.D – Partner
Ian Lane Ph.D – Partner
Michael Anstey Ph.D – Partner
Portfolio
Riverlane
Pretzel Therapeutics
Epitopea
Microbiotica
Seldon
Salience Labs
CMR Surgical
PragmatIC Semiconductor
Secondmind